151 related articles for article (PubMed ID: 23128493)
1. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
Hu M; Liu Q; Song P; Zhan X; Luo M; Liu C; Yang D; Cai Y; Zhang F; Jiang F; Zhang Y; Tang M; Zuo G; Zhou L; Luo J; Shi Q; Weng Y
Oncol Rep; 2013 Jan; 29(1):185-92. PubMed ID: 23128493
[TBL] [Abstract][Full Text] [Related]
2. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
3. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
4. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.
Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E
Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.
Akagami M; Kawada K; Kubo H; Kawada M; Takahashi M; Kaganoi J; Kato S; Itami A; Shimada Y; Watanabe G; Sakai Y
Ann Surg Oncol; 2011 Dec; 18(13):3868-77. PubMed ID: 21452064
[TBL] [Abstract][Full Text] [Related]
6. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
Wang C; Guo LB; Ma JY; Li YM; Liu HM
Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
[TBL] [Abstract][Full Text] [Related]
8. Antibody-based proteomics for esophageal cancer: Identification of proteins in the nuclear factor-kappaB pathway and mitotic checkpoint.
Uemura N; Nakanishi Y; Kato H; Nagino M; Hirohashi S; Kondo T
Cancer Sci; 2009 Sep; 100(9):1612-22. PubMed ID: 19558549
[TBL] [Abstract][Full Text] [Related]
9. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nemo-like kinase increases taxol sensitivity in laryngeal cancer.
Dong JR; Guo N; Zhao JP; Liu PD; Feng HH; Li Y
Asian Pac J Cancer Prev; 2013; 14(12):7137-41. PubMed ID: 24460265
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
[TBL] [Abstract][Full Text] [Related]
12. BubR1 is required for a sustained mitotic spindle checkpoint arrest in human cancer cells treated with tubulin-targeting pyrrolo-1,5-benzoxazepines.
Greene LM; Campiani G; Lawler M; Williams DC; Zisterer DM
Mol Pharmacol; 2008 Feb; 73(2):419-30. PubMed ID: 17991869
[TBL] [Abstract][Full Text] [Related]
13. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
15. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
[TBL] [Abstract][Full Text] [Related]
19. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.
Ha GH; Baek KH; Kim HS; Jeong SJ; Kim CM; McKeon F; Lee CW
Cancer Res; 2007 Aug; 67(15):7155-64. PubMed ID: 17671183
[TBL] [Abstract][Full Text] [Related]
20. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
Bu Y; Yang Z; Li Q; Song F
Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
